Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice

J Biol Chem. 2019 Aug 2;294(31):11772-11784. doi: 10.1074/jbc.RA119.007660. Epub 2019 Jun 12.

Abstract

Enhanced osteoclast-mediated bone resorption and diminished formation may promote bone loss. Pleckstrin homology (PH) domain and leucine-rich repeat protein phosphatase 1 (Phlpp1) regulates protein kinase C (PKC) and other proteins in the control of bone mass. Germline Phlpp1 deficiency reduces bone volume, but the mechanisms remain unknown. Here, we found that conditional Phlpp1 deletion in murine osteoclasts increases their numbers, but also enhances bone mass. Despite elevating osteoclasts, Phlpp1 deficiency did not increase serum markers of bone resorption, but elevated serum markers of bone formation. These results suggest that Phlpp1 suppresses osteoclast formation and production of paracrine factors controlling osteoblast activity. Phlpp1 deficiency elevated osteoclast numbers and size in ex vivo osteoclastogenesis assays, accompanied by enhanced expression of proto-oncogene C-Fms (C-Fms) and hyper-responsiveness to macrophage colony-stimulating factor (M-CSF) in bone marrow macrophages. Although Phlpp1 deficiency increased TRAP+ cell numbers, it suppressed actin-ring formation and bone resorption in these assays. We observed that Phlpp1 deficiency increases activity of PKCζ, a PKC isoform controlling cell polarity, and that addition of a PKCζ pseudosubstrate restores osteoclastogenesis and bone resorption of Phlpp1-deficient osteoclasts. Moreover, Phlpp1 deficiency increased expression of the bone-coupling factor collagen triple helix repeat-containing 1 (Cthrc1). Conditioned growth medium derived from Phlpp1-deficient osteoclasts enhanced mineralization of ex vivo osteoblast cultures, an effect that was abrogated by Cthrc1 knockdown. In summary, Phlpp1 critically regulates osteoclast numbers, and Phlpp1 deficiency enhances bone mass despite higher osteoclast numbers because it apparently disrupts PKCζ activity, cell polarity, and bone resorption and increases secretion of bone-forming Cthrc1.

Keywords: Akt PKB; bone resorption; cell polarity; collagen triple helix repeat containing 1 (CTHRC1); colony-stimulating factor 1 receptor (CSF1R), mineralization; cytoskeleton; macrophage colony-stimulating factor (M-CSF); phosphatase; protein kinase C (PKC); protein kinase C zeta (PKC ζ).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Density
  • Bone Resorption / metabolism
  • Bone Resorption / pathology
  • Bone and Bones / diagnostic imaging
  • Bone and Bones / physiology
  • Cell Differentiation / drug effects
  • Culture Media, Conditioned / pharmacology
  • Extracellular Matrix Proteins / metabolism
  • Female
  • Macrophage Colony-Stimulating Factor / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Osteoclasts / cytology
  • Osteoclasts / metabolism
  • Osteogenesis* / drug effects
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Phosphoprotein Phosphatases / genetics
  • Phosphoprotein Phosphatases / metabolism*
  • Protein Kinase C / metabolism
  • RNA Interference
  • RNA, Small Interfering / metabolism

Substances

  • Cthrc1 protein, mouse
  • Culture Media, Conditioned
  • Extracellular Matrix Proteins
  • RNA, Small Interfering
  • Macrophage Colony-Stimulating Factor
  • protein kinase C zeta
  • Protein Kinase C
  • PHLPP1 protein, mouse
  • Phosphoprotein Phosphatases